HTG Molecular Diagnostics (HTGM) Reports Q1 Loss of $0.22/Share

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q1 EPS of ($0.22), versus ($0.73) reported last year. Revenue for the quarter came in at $4.2 million, versus $1.37 million reported last year.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Gaming and Leisure Properties (GLPI) Misses Q1 EPS by 6c
• Associated Banc-Corp (ASB) Tops Q1 EPS by 3c